首页 > 市场调查报告书 > 食物/饮料

机能性食品

市场调查报告书

商品编码

1554271

眼保健补充品市场规模、份额、成长分析：按成分类型、适应症、配方、地区 - 产业预测，2024-2031 年

Eye Health Supplements Market Size, Share, Growth Analysis, By Ingredient Type, By Indication, By Formulation, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球眼补充品市场规模为17.9亿美元，从2023年的19亿美元成长到2031年的30亿美元，预测期间（2024-2031年）复合年增长率为5.9%。

由于视力障碍和近视的盛行率不断增加，特别是在 COVID-19 大流行期间萤幕时间的增加和远距工作加剧了眼保健补充品市场的显着增长，我正在实现这一目标。高度近视会增加白内障、青光眼和老龄化黄斑部病变等进行进行性眼科疾病的风险，因此受数位眼疲劳影响的老年人和千禧世代的眼睛健康都面临风险。此外，老龄化黄斑部病变（AMD）、干眼症、白内障和发炎等疾病的盛行率不断上升，以及眼科医生提倡使用补充品来预防和控制这些疾病，也推动了市场的发展。世界卫生组织 (WHO) 估计，全球有 22 亿人患有视力丧失或失明，其中贫困地区的比例高于高所得国家。这种差异正在促使已开发国家的消费者在眼睛保健补充品上花费更多，而透过直销和电子商务增加叶黄素、玉米黄质和越橘萃取补充品的供应也正在推动市场扩张。 Bausch & Lomb 的 PreserVision AREDS 2 Formula 微凝胶眼维生素等新产品的推出，满足了 10 亿视力丧失未得到治疗的人未得到满足的需求，并进一步推动市场成长。此外，眼保健补充品，在 COVID-19 大流行期间激增约 48.3%，凸显了支持该市场的强大销售和分销网络。

市场概况
北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Bausch Health Companies Inc.（Canada）
Vitabiotics Ltd.（UK）
Alcon Inc.（Switzerland）
The Nature's Bounty Co.（US）
Amway Corporation（US）
ZeaVision Holdings, Inc.（US）
Valeant Pharmaceuticals International, Inc.（Canada）
Swanson Health Products, Inc.（US）
GNC Holdings Inc.（US）
Nature's Way Products, LLC（US）
EyePromise（US）
Nutraceutical Corporation（US）
Vitafusion（US）
EyeScience Labs, LLC（US）
NOW Foods（US）
Ocuvite（Abbott Laboratories）（US）
Carlson Labs（US）

简介目录

Product Code: SQMIG35I2201

Global Eye Health Supplements Market size was valued at USD 1.79 Billion in 2022 and is expected to grow from USD 1.9 Billion in 2023 to reach USD 3 Billion by 2031, at a CAGR of 5.9 % during the forecast period (2024-2031).

The Eye Health Supplements Market is experiencing significant growth driven by the increasing prevalence of vision impairment and myopia, particularly exacerbated by heightened screen time and remote work during the COVID-19 pandemic. High myopia raises the risk of developing progressive eye conditions like cataracts, glaucoma, and age-related macular degeneration, prompting a surge in demand for eye health products among both the elderly and millennials affected by digital eye strain. The market is further supported by rising incidences of conditions such as Age-related Macular Degeneration (AMD), dry eye syndrome, cataracts, and inflammation, with ophthalmologists advocating for supplements to prevent and manage these disorders. The World Health Organization estimates that 2.2 billion people globally suffer from vision impairment or blindness, with poorer regions facing higher rates compared to high-income countries. This disparity drives consumer spending on eye health supplements in developed nations, while increased availability of Lutein, Zeaxanthin, and bilberry extract supplements through direct sales and e-commerce channels also fuels market expansion. New product launches, such as Bausch + Lomb's PreserVision AREDS 2 Formula micro gel eye vitamins, cater to the substantial unmet need among the 1 billion people with untreated vision impairment, further propelling market growth. Additionally, a notable increase in online sales of eye health supplements, which surged by approximately 48.3% during the COVID-19 pandemic, highlights the robust sales and distribution networks supporting this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Eye Health Supplements Market Segmental Analysis

The global eye health supplements Market is segmented into ingredient type, indication, formulation and region. Based on ingredient type, the market is segmented into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and others. Based on indication, the market is segmented into age-related macular degeneration (AMD), cataract, dry eye syndrome, inflammation, and others. Based on formulation, the market is segmented into tablets, capsules, powder, softgels, liquid and others. Based on region, the global Eye Health Supplements Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Eye Health Supplements Market

The Eye Health Supplements Market is experiencing significant growth due to the rising prevalence of eye-related disorders such as age-related macular degeneration (AMD), cataracts, and dry eye syndrome, driven by the increasing global aging population. This surge in eye conditions is expanding the demand for supplements that support eye health. Additionally, the market is being further fueled by the introduction of innovative products, exemplified by Healthy Directions' launch of Vision Essentials ULTRA, a groundbreaking one-a-day vision supplement in July 2022, and PharmaLinea's release of a range of preventative eye health supplements in user-friendly formats in May 2021.

Restraints in the Global Eye Health Supplements Market

The Eye Health Supplements Market faces significant restraints due to limited scientific evidence supporting their efficacy and long-term benefits, which may undermine consumer confidence and market acceptance. The market is also constrained by stringent regulatory guidelines, such as those imposed by the Food Safety and Standards Authority of India (FSSAI), which mandates that health supplements, including eye health products, adhere to specific Recommended Dietary Allowance (RDA) values. This regulatory pressure can limit market growth, particularly in emerging countries where high costs and limited availability further restrict market expansion. Additionally, the lack of robust clinical studies and standardized research methodologies contributes to market hesitation and slower adoption.

Market Trends of the Global Eye Health Supplements Market

The Eye Health Supplements Market is witnessing several notable trends driven by increasing consumer awareness and a proactive approach to eye care. As individuals become more informed about the importance of eye health and the prevention of age-related conditions, they are integrating eye health supplements into their wellness routines. There is also a rising preference for supplements made from natural and organic ingredients, with consumers seeking products free from synthetic additives and artificial components, prompting manufacturers to prioritize clean and transparent ingredient profiles. Additionally, the market is seeing a surge in supplements specifically formulated to address conditions such as age-related macular degeneration, cataracts, dry eye syndrome, and glaucoma, catering to targeted nutritional needs. Moreover, combination supplements, which blend vitamins, minerals, antioxidants, and other nutrients, are gaining popularity for their comprehensive support and convenience in addressing multiple nutritional requirements with a single product.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Macroeconomic Indicators
Top Investment Analysis

Eye Health Supplements Market by Ingredient Type

Market Overview
Lutein and Zeaxanthin
Antioxidants
Omega-3 Fatty acids
Coenzyme Q10
Flavonoids
Alpha-Lipoic Acid
Astaxanthin
Other

Eye Health Supplements Market by Indication

Market Overview
Age-related Macular Degeneration (AMD)
Cataract
Dry Eye Syndrome
Inflammation
Others

Eye Health Supplements Market by Formulation

Market Overview
Tablets
Capsules
Powder
Softgel
Liquid
Others

Eye Health Supplement Market Size by Region

Market Overview
North America
- USA
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Bausch Health Companies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitabiotics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Nature's Bounty Co. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amway Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZeaVision Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valeant Pharmaceuticals International, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swanson Health Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GNC Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nature's Way Products, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EyePromise (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutraceutical Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitafusion (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EyeScience Labs, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NOW Foods (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ocuvite (Abbott Laboratories) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carlson Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments